Abstract
Background: The COVID-19 pandemic has triggered a large number of publications to inform, understand, conduct more research and control the situation. Although the researchers are analyzing the bibliometrics on this condition, no bibliometric studies are available on the publications related to post-covid mucormycosis. This study is aimed at bibliometric assessment of the publications related to post-covid mucormycosis. Methods: In the presented study, authors have performed the bibliometric analysis of the World health organization (WHO) database named ‘Global literature on coronavirus disease.’ WHO is maintaining this database since the pandemic, and it contains thousands of reports. Two simple search terms, ‘Covid’ and ‘mucormycosis’ used to search the entire database in ‘title, abstract, subject’ mode with the search string was tw:(mucormycosis covid). The search was not restricted to any date range. Results: Only 51 reports (40 articles and 01 clinical trials) were obtained with the above search terms. The study found that there is considerable growth in such publication in the last 6 months. Interestingly only three such reports were published in the year 2020. Database wise 38 of these 51 reports were available in Medline. Most of such reports were published by Indian authors. Indian Journal of Ophthalmology emerged as the most productive journal contributing the highest number (10) of these reports. Conclusions: The highly acclaimed publications were the reviews. This study suggests that India is the most productive country for publications related to post-covid mucormycosis. This resembles the fact that the country, faced the excessive emergence of post-covid-19 mucormycosis cases reported the secondhighest number of Covid 19 cases in the substantial worldwide outbreak in the second wave, which is followed by post covid mucormycosis. Bangladesh Journal of Medical Science Vol.20(5) 2021 p.144-147
Highlights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), popularly known as Covid-19, is associated with an array of opportunistic bacterial and fungal infections[1]
There is a severe emergence of mucormycosis in patients with COVID-19 has been reported more and more all over the world, especially in India (majority rhino-orbitalcerebral mucormycosis (ROCM))[3]
World health organization (WHO) database named as ‘Global literature on coronavirus disease’[4] which is a comprehensive collection on Covid 19 related research including clinical trials
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), popularly known as Covid-19, is associated with an array of opportunistic bacterial and fungal infections[1]. The use of immunosuppressants, including steroidal therapy, is widespread in the early stage of infection, and it is used to prevent and treat the period of high inflammation of COVID-19. This diminishes the host immune response to the microorganisms and provides an excellent opportunity for the other bacterial and fungal infections[2]. The researchers are analyzing the bibliometrics on this condition, no bibliometric studies are available on the publications related to post-covid mucormycosis. This study is aimed at bibliometric assessment of the publications related to post-covid mucormycosis
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
